KONINKLIJKE PHILIPS NVR- NY (PHG) Stock Fundamental Analysis

NYSE:PHG • US5004723038

30.96 USD
-0.52 (-1.65%)
At close: Feb 19, 2026
30.81 USD
-0.15 (-0.48%)
Pre-Market: 2/20/2026, 6:24:57 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PHG. PHG was compared to 185 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of PHG while its profitability can be described as average. PHG has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year PHG was profitable.
  • In the past year PHG had a positive cash flow from operations.
  • In multiple years PHG reported negative net income over the last 5 years.
  • Of the past 5 years PHG 4 years had a positive operating cash flow.
PHG Yearly Net Income VS EBIT VS OCF VS FCFPHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.32%, PHG is in the better half of the industry, outperforming 79.46% of the companies in the same industry.
  • PHG has a better Return On Equity (8.17%) than 82.16% of its industry peers.
  • The Return On Invested Capital of PHG (5.79%) is better than 77.84% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PHG is significantly below the industry average of 8.75%.
  • The 3 year average ROIC (3.64%) for PHG is below the current ROIC(5.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROIC 5.79%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.64%
ROIC(5y)N/A
PHG Yearly ROA, ROE, ROICPHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • PHG has a better Profit Margin (5.02%) than 77.30% of its industry peers.
  • In the last couple of years the Profit Margin of PHG has declined.
  • PHG has a Operating Margin of 7.98%. This is in the better half of the industry: PHG outperforms 74.59% of its industry peers.
  • PHG's Operating Margin has declined in the last couple of years.
  • PHG has a Gross Margin of 45.18%. This is in the lower half of the industry: PHG underperforms 61.08% of its industry peers.
  • In the last couple of years the Gross Margin of PHG has remained more or less at the same level.
Industry RankSector Rank
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
OM growth 3YN/A
OM growth 5Y-5.59%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
PHG Yearly Profit, Operating, Gross MarginsPHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHG is destroying value.
  • The number of shares outstanding for PHG has been increased compared to 1 year ago.
  • The number of shares outstanding for PHG has been increased compared to 5 years ago.
  • Compared to 1 year ago, PHG has a worse debt to assets ratio.
PHG Yearly Shares OutstandingPHG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
PHG Yearly Total Debt VS Total AssetsPHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • PHG has a debt to FCF ratio of 16.37. This is a negative value and a sign of low solvency as PHG would need 16.37 years to pay back of all of its debts.
  • PHG has a Debt to FCF ratio of 16.37. This is in the better half of the industry: PHG outperforms 70.81% of its industry peers.
  • A Debt/Equity ratio of 0.63 indicates that PHG is somewhat dependend on debt financing.
  • PHG has a worse Debt to Equity ratio (0.63) than 64.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Altman-Z N/A
ROIC/WACC0.87
WACC6.65%
PHG Yearly LT Debt VS Equity VS FCFPHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that PHG should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.32, PHG is doing worse than 78.38% of the companies in the same industry.
  • A Quick Ratio of 0.94 indicates that PHG may have some problems paying its short term obligations.
  • PHG has a Quick ratio of 0.94. This is in the lower half of the industry: PHG underperforms 79.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.94
PHG Yearly Current Assets VS Current LiabilitesPHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.11% over the past year.
  • PHG shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.62% yearly.
  • Looking at the last year, PHG shows a decrease in Revenue. The Revenue has decreased by -1.04% in the last year.
  • The Revenue has been growing slightly by 0.59% on average over the past years.
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%

3.2 Future

  • PHG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.42% yearly.
  • Based on estimates for the next years, PHG will show a small growth in Revenue. The Revenue will grow by 3.77% on average per year.
EPS Next Y3.51%
EPS Next 2Y8.11%
EPS Next 3Y15.73%
EPS Next 5Y8.42%
Revenue Next Year1.71%
Revenue Next 2Y3.03%
Revenue Next 3Y3.53%
Revenue Next 5Y3.77%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHG Yearly Revenue VS EstimatesPHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHG Yearly EPS VS EstimatesPHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.90, PHG is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of PHG indicates a rather cheap valuation: PHG is cheaper than 85.95% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.09. PHG is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 17.31, which indicates a rather expensive current valuation of PHG.
  • 84.86% of the companies in the same industry are more expensive than PHG, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.98, PHG is valued a bit cheaper.
Industry RankSector Rank
PE 17.9
Fwd PE 17.31
PHG Price Earnings VS Forward Price EarningsPHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 87.03% of the companies in the same industry are more expensive than PHG, based on the Enterprise Value to EBITDA ratio.
  • PHG's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. PHG is cheaper than 74.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF 51.35
EV/EBITDA 12.03
PHG Per share dataPHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as PHG's earnings are expected to grow with 15.73% in the coming years.
PEG (NY)5.09
PEG (5Y)N/A
EPS Next 2Y8.11%
EPS Next 3Y15.73%

6

5. Dividend

5.1 Amount

  • PHG has a Yearly Dividend Yield of 3.81%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.20, PHG pays a better dividend. On top of this PHG pays more dividend than 98.92% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.85, PHG pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.81%

5.2 History

  • On average, the dividend of PHG grows each year by 216.55%, which is quite nice.
  • PHG has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)216.55%
Div Incr Years0
Div Non Decr Years0
PHG Yearly Dividends per sharePHG Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 36.65% of the earnings are spent on dividend by PHG. This is a low number and sustainable payout ratio.
  • The dividend of PHG is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP36.65%
EPS Next 2Y8.11%
EPS Next 3Y15.73%
PHG Yearly Income VS Free CF VS DividendPHG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B 4B
PHG Dividend Payout.PHG Dividend Payout, showing the Payout Ratio.PHG Dividend Payout.PayoutRetained Earnings

KONINKLIJKE PHILIPS NVR- NY

NYSE:PHG (2/19/2026, 8:25:31 PM)

Premarket: 30.81 -0.15 (-0.48%)

30.96

-0.52 (-1.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners44.83%
Inst Owner Change-0.37%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap29.81B
Revenue(TTM)17.83B
Net Income(TTM)895.00M
Analysts73.33
Price Target32.34 (4.46%)
Short Float %0.22%
Short Ratio1.93
Dividend
Industry RankSector Rank
Dividend Yield 3.81%
Yearly Dividend0.41
Dividend Growth(5Y)216.55%
DP36.65%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.02%
Min EPS beat(2)3.95%
Max EPS beat(2)14.1%
EPS beat(4)4
Avg EPS beat(4)17.83%
Min EPS beat(4)3.95%
Max EPS beat(4)31.04%
EPS beat(8)4
Avg EPS beat(8)2.84%
EPS beat(12)6
Avg EPS beat(12)6.47%
EPS beat(16)7
Avg EPS beat(16)6.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)-0.86%
Revenue beat(8)0
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-2.36%
Revenue beat(16)2
Avg Revenue beat(16)-1.72%
PT rev (1m)0.45%
PT rev (3m)1.81%
EPS NQ rev (1m)-15.5%
EPS NQ rev (3m)-15.5%
EPS NY rev (1m)-0.33%
EPS NY rev (3m)-0.56%
Revenue NQ rev (1m)3.12%
Revenue NQ rev (3m)3.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.59%
Valuation
Industry RankSector Rank
PE 17.9
Fwd PE 17.31
P/S 1.42
P/FCF 51.35
P/OCF 21.83
P/B 2.31
P/tB N/A
EV/EBITDA 12.03
EPS(TTM)1.73
EY5.59%
EPS(NY)1.79
Fwd EY5.78%
FCF(TTM)0.6
FCFY1.95%
OCF(TTM)1.42
OCFY4.58%
SpS21.77
BVpS13.37
TBVpS-1.08
PEG (NY)5.09
PEG (5Y)N/A
Graham Number22.82
Profitability
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROCE 7.33%
ROIC 5.79%
ROICexc 6.76%
ROICexgc 23.43%
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
FCFM 2.77%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.64%
ROIC(5y)N/A
ROICexc(3y)4.17%
ROICexc(5y)N/A
ROICexgc(3y)14.41%
ROICexgc(5y)N/A
ROCE(3y)4.62%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.31%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.82%
OM growth 3YN/A
OM growth 5Y-5.59%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Debt/EBITDA 2.72
Cap/Depr 59.38%
Cap/Sales 3.75%
Interest Coverage 5.63
Cash Conversion 45.59%
Profit Quality 55.2%
Current Ratio 1.32
Quick Ratio 0.94
Altman-Z N/A
F-Score7
WACC6.65%
ROIC/WACC0.87
Cap/Depr(3y)53.03%
Cap/Depr(5y)53.41%
Cap/Sales(3y)3.68%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
EPS Next Y3.51%
EPS Next 2Y8.11%
EPS Next 3Y15.73%
EPS Next 5Y8.42%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%
Revenue Next Year1.71%
Revenue Next 2Y3.03%
Revenue Next 3Y3.53%
Revenue Next 5Y3.77%
EBIT growth 1Y15922.2%
EBIT growth 3YN/A
EBIT growth 5Y-5.03%
EBIT Next Year63.55%
EBIT Next 3YN/A
EBIT Next 5Y17.05%
FCF growth 1Y-43.86%
FCF growth 3YN/A
FCF growth 5Y-22.31%
OCF growth 1Y-25.32%
OCF growth 3YN/A
OCF growth 5Y-15.14%

KONINKLIJKE PHILIPS NVR- NY / PHG FAQ

What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PHG.


Can you provide the valuation status for KONINKLIJKE PHILIPS NVR- NY?

ChartMill assigns a valuation rating of 5 / 10 to KONINKLIJKE PHILIPS NVR- NY (PHG). This can be considered as Fairly Valued.


How profitable is KONINKLIJKE PHILIPS NVR- NY (PHG) stock?

KONINKLIJKE PHILIPS NVR- NY (PHG) has a profitability rating of 5 / 10.


How financially healthy is KONINKLIJKE PHILIPS NVR- NY?

The financial health rating of KONINKLIJKE PHILIPS NVR- NY (PHG) is 2 / 10.


Is the dividend of KONINKLIJKE PHILIPS NVR- NY sustainable?

The dividend rating of KONINKLIJKE PHILIPS NVR- NY (PHG) is 6 / 10 and the dividend payout ratio is 36.65%.